The donation, the result of the solidarity campaigns organized by the Association throughout 2022, will be used to finance the generation of a new experimental model for the study of predisposition to cancer, a project based on personalized medicine, and the use of stem cells to modeling diseases.
The work focuses on endogenous blood stem cell rejuvenation as a possible strategy to regenerate tissues and improve the health and life expectancy of the elderly.
A drug that boosts the regeneration of stem cells extends life expectancy in mice Read More »
Although further research is needed to determine whether the identification of genetic markers may lead to the development of new targeted treatments, these findings help to understand how these markers may condition the pathology of suicidal thoughts and actions.
Identified four genes that increase the risk of suicidal thoughts and acts Read More »
Today the Niemann-Pick Spain Foundation came to deliver the check for 71,056.25 euros that will fully finance a pilot study to determine the efficacy and safety of the drug Efavirenz to alleviate the cognitive deterioration of patients with this minority disease of genetic origin and for which there is currently no treatment. The event was
This is the largest study on the genetics of colorectal cancer risk. The study, carried out by a global consortium, with the participation of IDIBELL and the Catalan Institute of Oncology, opens new strategies for treatment and chemoprevention.
Funded projects address different areas of health, from precision radiotherapy to the search for therapies for breast cancer and other diseases.
The Ministry of Science and Innovation and the State Research Agency, in the call for Grants for the Preparation and Management of European Projects, have financed the project “UPDATE – SUPporting IDIBELL reseArchers To succeed in Horizon Europe”.
Funded the UPDATE project that will promote the leadership of IDIBELL in Horizon Europe Read More »
